While a similar effect on tumor growth and metastasis was achieved via inhibition of metabolic reprogramming in breast cancer cells expressing an intracellular form of CYTL1 that lacked a 1-22 aa signal peptide, ΔCYTL1 (73). This evidence concerns the gene CYTL1 and breast carcinoma.